Cargando…
Nuclear G protein-coupled oestrogen receptor (GPR30) predicts poor survival in patients with ovarian cancer
OBJECTIVE: To demonstrate the correlation between nuclear and cytoplasmic G protein-coupled oestrogen receptor (GPR30) expression and clinicopathological features and outcome in patients with ovarian cancer. METHODS: Nuclear and cytoplasmic GPR30 expressions were determined using immunohistochemistr...
Autores principales: | Zhu, Cai-xia, Xiong, Wei, Wang, Ma-lie, Yang, Juan, Shi, Hui-juan, Chen, Han-qing, Niu, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5971494/ https://www.ncbi.nlm.nih.gov/pubmed/29239277 http://dx.doi.org/10.1177/0300060517717625 |
Ejemplares similares
-
Localisation of GPR30, a novel G protein-coupled oestrogen receptor, suggests multiple functions in rodent brain and peripheral tissues
por: Hazell, Georgina G J, et al.
Publicado: (2009) -
The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer
por: Kolkova, Zuzana, et al.
Publicado: (2012) -
The G-Protein-Coupled Estrogen Receptor (GPER/GPR30) in Ovarian Granulosa Cell Tumors
por: Heublein, Sabine, et al.
Publicado: (2014) -
G-Protein Coupled Receptor 30 (GPR30): A Novel Regulator of Endothelial Inflammation
por: Chakrabarti, Subhadeep, et al.
Publicado: (2012) -
G-protein Coupled Estrogen Receptor (GPER/GPR30) and Women's Health
por: Kim, Mi-Jin, et al.
Publicado: (2015)